Sam Altman recently funded biotech startup Retro BioScience with $180 million, leading experts to suggest that the first anti-aging pills may hit shelves in 2028. Silicon Valley is racing to conquer death, and Altman is among the tech leaders who are investing in this area.
Pills that can help a person reverse the effects of aging could be on the market in the next five years, according to an expert.
Sam Altman, 37, was revealed to have funded biotech startup Retro BioScience to the tune ...
